Evidence map›Paper›PMID 34442005›Full record

ArticleJournal of clinical medicine2021

Differential Effects of Comorbid Psychiatric Disorders on Treatment Outcome in Posttraumatic Stress Disorder from Childhood Trauma.

Nele Assmann, Eva Fassbinder, Anja Schaich, Christopher W Lee, Katrina Boterhoven de Haan, Marleen Rijkeboer, Arnoud Arntz

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Nele AssmannDepartment of Psychiatry and Psychotherapy, Lübeck University, 23538 Lübeck, Germany.
Eva FassbinderDepartment of Psychiatry and Psychotherapy, Lübeck University, 23538 Lübeck, Germany.
Anja SchaichDepartment of Psychiatry and Psychotherapy, Lübeck University, 23538 Lübeck, Germany.
Christopher W LeeFaculty of Health and Medical Sciences, University of Western Australia, Perth, WA 6009, Australia.ORCID 0000-0001-8902-9480
Katrina Boterhoven de HaanFaculty of Health and Medical Sciences, University of Western Australia, Perth, WA 6009, Australia.ORCID 0000-0002-2164-9365
Marleen RijkeboerDepartment of Clinical Psychological Science, Faculty of Psychology and Neuroscience, Maastricht University, 6200 MD Maastricht, The Netherlands.
Arnoud ArntzDepartment of Clinical Psychology, University of Amsterdam, 1000 GG Amsterdam, The Netherlands.
Christian-Albrechts-Universität zu Kiel · DEThe University of Western Australia · AUMaastricht University · NLUniversity of Amsterdam · NL

Funding

Anxiety Disorders Foundation of Western Australia PG51012100Commonwealth Government 'Australian Government Research Training Program Fees Offset'EMDR Research Foundation PG10400309
6 · The paper itself

Abstract

Patients with posttraumatic stress disorder (PTSD) frequently have comorbid diagnoses such as major depressive disorder (MDD) and anxiety disorders (AD). Studies into the impact of these comorbidities on the outcome of PTSD treatment have yielded mixed results. The different treatments investigated in these studies might explain the varied outcome. The purpose of this study was to examine the impact of these comorbidities on the outcome of two specific PTSD treatments. MDD and AD were analyzed as predictors and moderators in a trial comparing 12 sessions of either eye movement desensitization and reprocessing (EMDR) or imagery rescripting (IR) in 155 adult patients with PTSD from childhood trauma. The primary outcome was reduction of PTSD symptoms (clinician-administered PTSD Scale for DSM-5, CAPS-5) assessed at eight-week follow-up and a secondary outcome was self-report PTSD symptoms (Impact of Event Scale, IES-R). MDD was not a predictor of treatment outcome but did have a significant moderator effect. Patients with MDD showed a better outcome if they were treated with IR, whereas patients without MDD improved more in the EMDR condition. No impact of AD emerged. It seems essential to consider comorbid MDD when planning PTSD treatment to improve treatment outcomes. More research is needed to replicate our findings and focus on different kinds of PTSD treatments and other comorbidities.

Indexed as

anxiety disorderdepressionmoderatorposttraumatic stress disorderpredictiontherapytreatment outcome

Identifiers

PMID34442005
PMCPMC8397108
OpenAlexW3193873887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.